PL377714A1 - Białka oddziałujące z receptorową tyrozynową fosfatazą białkową DEP-1 oraz sposoby ich wykorzystania - Google Patents

Białka oddziałujące z receptorową tyrozynową fosfatazą białkową DEP-1 oraz sposoby ich wykorzystania

Info

Publication number
PL377714A1
PL377714A1 PL377714A PL37771403A PL377714A1 PL 377714 A1 PL377714 A1 PL 377714A1 PL 377714 A PL377714 A PL 377714A PL 37771403 A PL37771403 A PL 37771403A PL 377714 A1 PL377714 A1 PL 377714A1
Authority
PL
Poland
Prior art keywords
dep
receptor protein
protein tyrosine
related methods
tyrosine phosphatase
Prior art date
Application number
PL377714A
Other languages
English (en)
Inventor
Helena L. Palka-Hamblin
Nicholas K. Tonks
Original Assignee
Cold Spring Harbor Laboratory
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cold Spring Harbor Laboratory filed Critical Cold Spring Harbor Laboratory
Publication of PL377714A1 publication Critical patent/PL377714A1/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/16—Hydrolases (3) acting on ester bonds (3.1)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/502—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects
    • G01N33/5041—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects involving analysis of members of signalling pathways

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Zoology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Hematology (AREA)
  • Toxicology (AREA)
  • Urology & Nephrology (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • General Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
PL377714A 2002-11-26 2003-11-26 Białka oddziałujące z receptorową tyrozynową fosfatazą białkową DEP-1 oraz sposoby ich wykorzystania PL377714A1 (pl)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US42974602P 2002-11-26 2002-11-26

Publications (1)

Publication Number Publication Date
PL377714A1 true PL377714A1 (pl) 2006-02-06

Family

ID=32393583

Family Applications (1)

Application Number Title Priority Date Filing Date
PL377714A PL377714A1 (pl) 2002-11-26 2003-11-26 Białka oddziałujące z receptorową tyrozynową fosfatazą białkową DEP-1 oraz sposoby ich wykorzystania

Country Status (6)

Country Link
US (2) US7205121B2 (pl)
EP (1) EP1576139A4 (pl)
AU (1) AU2003298761A1 (pl)
CA (1) CA2503736A1 (pl)
PL (1) PL377714A1 (pl)
WO (1) WO2004048549A2 (pl)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7176289B1 (en) * 1998-09-11 2007-02-13 Vanderbilt University Modulation of endothelial cell surface receptor activity in the regulation of angiogenesis
CA2561823A1 (en) * 2004-04-23 2005-12-15 Amgen Inc. Antibodies of angiogenesis inhibiting domains of cd148
GB201521894D0 (en) 2015-12-11 2016-01-27 Immatics Biotechnologies Gmbh Novel peptides and combination of peptides for use in immunotherapy against various cancers
PE20230343A1 (es) 2015-12-11 2023-03-01 Immatics Biotechnologies Gmbh Peptidos que estimulan respuestas inmunitarias antitumorales
EP3818153B1 (en) 2018-07-06 2023-12-13 The Regents Of The University Of Colorado Genetically encoded system for constructing and detecting biologically active agents
CA3215311A1 (en) * 2021-04-01 2022-10-06 The Regents Of The University Of California Genetic modification of mammalian cells to confer resistance to csf1r antagonists

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69530261T3 (de) * 1994-05-03 2008-07-03 Cold Spring Harbor Laboratory Durch Zelldichte stimulierte Protein-Tyrosin-Phosphatasen
US5912138A (en) * 1996-07-25 1999-06-15 Cold Spring Harbor Laboratory Substrate trapping protein tyrosine phosphatases
US6248327B1 (en) * 1998-09-11 2001-06-19 Vanderbilt University Modulation of endothelial cell surface receptor activity in the regulation of angiogenesis
CA2375145A1 (en) 1999-06-03 2000-12-14 Cold Spring Harbor Laboratory Substrate trapping protein tyrosine phosphatases
MXPA02008462A (es) * 2000-03-01 2004-05-14 Univ Vanderbilt Modulacion de la actividad de receptor de superficie celular endotelial en la regulacion de angiogenesis.
AU2760602A (en) * 2001-03-23 2002-09-26 Agouron Pharmaceuticals, Inc. Catalytic domains of the human hepatocyte growth factor receptor tyrosine kinase, and materials and methods for identification of inhibitors thereof

Also Published As

Publication number Publication date
US7205121B2 (en) 2007-04-17
EP1576139A4 (en) 2007-06-20
US20080026423A1 (en) 2008-01-31
EP1576139A2 (en) 2005-09-21
CA2503736A1 (en) 2004-06-10
WO2004048549A3 (en) 2006-02-16
US20040161821A1 (en) 2004-08-19
AU2003298761A1 (en) 2004-06-18
WO2004048549A2 (en) 2004-06-10

Similar Documents

Publication Publication Date Title
EP1448588A4 (en) ANTIBODIES AND MULTIMERS OF PSMA PROTEINS
IL192111A0 (en) Human receptor proteins; related reagents and methods
GB0218205D0 (en) Human ZZAP1 protein
EP1362235A4 (en) PEPTIDE OR PROTEIN MICROASSAY METHOD AND DEVICE
EP1532173A4 (en) PROTEIN ANALYSIS
AU2003226899A8 (en) Human diabetes-mediating proteins
PL377714A1 (pl) Białka oddziałujące z receptorową tyrozynową fosfatazą białkową DEP-1 oraz sposoby ich wykorzystania
EP1366360A4 (en) PROCESS FOR PROTEIN COMPARISON IN THE LARGE RANGE
AU2003252075A8 (en) Human immunosuppressive protein
AU2003262638A8 (en) Biotinylation of proteins
GB0208089D0 (en) Protein
GB0306428D0 (en) Receptor proteins
AU2003278718A8 (en) Stars-a muscle-specification-binding protein
GB0202334D0 (en) Protein analysis
GB0123858D0 (en) Method for analysing protein/peptide expression
GB0128161D0 (en) Receptor protein
EP1549951A4 (en) SEMAPHORIN-LIKE PROTEINS AND METHODS OF USE THEREOF
AU2003280316A8 (en) Zymogen-like protein c polypeptides
GB0223877D0 (en) Receptor proteins
GB0220459D0 (en) Receptor proteins
GB0108521D0 (en) Protein analysis
GB0204735D0 (en) Protein
GB0224307D0 (en) Protein sequence determination
GB0207141D0 (en) Modified protein
GB0203155D0 (en) Protein

Legal Events

Date Code Title Description
DISC Decisions on discontinuance of the proceedings (taken after the publication of the particulars of the applications)